Pinealon
EDR peptide / Glu-Asp-Arg
Pinealon is a short synthetic tripeptide (Glu-Asp-Arg) developed by Professor Vladimir Khavinson as part of the bioregulator peptide class, designed to target and normalize pineal gland function. It belongs to a family of ultrashort peptides theorized to penetrate cell nuclei and interact directly with DNA to regulate gene expression in specific tissue types. Primary research applications include circadian rhythm regulation, neuroprotection, and normalization of melatonin synthesis in aging populations.
Mecanismo de Ação
Synthetic tripeptide bioregulator that penetrates cell membranes and interacts with DNA in the promoter region of genes involved in neurodifferentiation. Promotes neuronal survival, reduces oxidative stress in brain tissue, and modulates circadian rhythm via pineal gland function.
Protocolos de Pesquisa
Para fins de pesquisa apenas. Não é conselhos médicos.
Research protocols (Khavinson method) use 10-20mg orally or sublingually daily for 10-30 day cycles. Sublingual administration may improve bioavailability. Cycles repeated every 3-6 months.
Notas de Pesquisa
Clinical Research Status
Pinealon has been studied primarily in Russian clinical research settings, with publications appearing in Russian biomedical journals and the St. Petersburg Institute of Bioregulation and Gerontology. Clinical studies in elderly patients have reported improvements in sleep quality, cognitive function, and normalization of melatonin cycling following oral or intranasal administration. It is registered and available as a dietary supplement in Russia but has not undergone Western regulatory review or FDA evaluation.
Key Published Findings
Research by Khavinson's group demonstrates that Pinealon can penetrate cell membranes and nuclear envelopes to interact with specific DNA sequences, potentially regulating gene expression related to pineal gland function. In vitro studies show the peptide promotes neuronal survival under oxidative stress conditions and normalizes circadian gene expression patterns. Animal studies indicate restoration of melatonin synthesis capacity in aged rats and improvement of learning and memory in models of accelerated aging.
Safety Profile
As a naturally occurring amino acid sequence found in human tissue, Pinealon is reported to have an excellent safety profile with no documented adverse effects in available clinical literature. The tripeptide structure is rapidly metabolized into constituent amino acids (glutamic acid, aspartic acid, arginine), minimizing accumulation risk. No drug interactions have been formally documented, though caution is theoretically warranted when combining with exogenous melatonin or other sleep-modulating compounds.
Comparison to Related Compounds
Pinealon differs from exogenous melatonin supplementation by theoretically restoring endogenous melatonin production capacity rather than simply replacing the hormone. Compared to the related Khavinson peptide Epithalon (which targets telomerase in the pineal gland), Pinealon focuses on functional normalization rather than cellular longevity mechanisms. Within the bioregulator peptide family, each compound is tissue-specific: Pinealon targets the pineal gland, Cortexin targets the brain cortex, and Retinalamin targets the retina.
Community Observations
Users typically report improved sleep onset latency and sleep quality within 1-2 weeks of sublingual or intranasal administration. Some users prefer Pinealon over exogenous melatonin due to the absence of morning grogginess and more natural-feeling sleep architecture. Sourcing is primarily limited to Russian pharmacies or specialized peptide suppliers, with quality verification being a common concern in the community.
Meio-Vivo
~15-30 minutes
Reconstituição
N/A (typically oral/sublingual capsule)
Armazenamento
Liofilizado
Room temperature. Protect from moisture.
Reconstituído
N/A (oral form)
Situação Legal nos EUA
Também Conhecido Como
Perguntas frequentes
O que é Pinealon?
Pinealon is a short synthetic tripeptide (Glu-Asp-Arg) developed by Professor Vladimir Khavinson as part of the bioregulator peptide class, designed to target and normalize pineal gland function. It belongs to a family of ultrashort peptides theorized to penetrate cell nuclei and interact directly with DNA to regulate gene expression in specific tissue types. Primary research applications include circadian rhythm regulation, neuroprotection, and normalization of melatonin synthesis in aging populations.
Como Pinealon funciona?
Synthetic tripeptide bioregulator that penetrates cell membranes and interacts with DNA in the promoter region of genes involved in neurodifferentiation. Promotes neuronal survival, reduces oxidative stress in brain tissue, and modulates circadian rhythm via pineal gland function.
Qual é o status regulatório de Pinealon nos EUA?
Research chemical (not FDA-approved)
Qual é a meia-vida de Pinealon?
~15-30 minutes
Por quais outros nomes Pinealon é conhecido?
EDR peptide, Glu-Asp-Arg
Peptide Contacts fornece resumos baseados em pesquisas apenas para fins informativos. Não hospedamos, distribuímos ou endossamos documentação de fornecedores. Todas as certificações de análise completa, certificados GMP e comunicações de fornecedores devem ser solicitadas e verificadas diretamente pelo comprador. Nada nesta plataforma constitui conselhos legais, médicos ou profissionais. Os usuários são unicamente responsáveis por verificar as credenciais dos fornecedores e garantir a conformidade com todas as leis locais, estaduais e federais aplicáveis antes de adquirir qualquer química de pesquisa. O uso desta plataforma constitui aceitação plena da responsabilidade pessoal.
Leia a declaração completa